We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AdvaMed Urges Supreme Court Not to ‘Stifle Innovation’ in Two False Claims Act Cases
AdvaMed Urges Supreme Court Not to ‘Stifle Innovation’ in Two False Claims Act Cases
AdvaMed has submitted an amicus brief to the U.S. Supreme Court in support of two supermarket chains accused of violating the False Claims Act by misreporting their drug prices, arguing that the errors were due to complex and sometimes conflicting regulations.